Gas Chromatography-Mass Spectroscopy-Based Metabolomics Analysis Reveals Potential Biochemical Markers for Diagnosis of Gestational Diabetes Mellitus – ProgerOmics

Identification of biomarkers to monitor the progression of Hutchinson-Gilford progeria syndrome

European Joint Progamme Rare Diseases 2022: "Development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases”

This web is funded under the Project AC22/00020, funded by Instituto de Salud Carlos III (ISCIII) with Next Generation EU funds, which funds actions related to Mecanismo de Recuperación y Resiliencia (MRR) within the European Joint Programme Rare Diseases framework.